Last $4.73 USD
Change Today -0.06 / -1.25%
Volume 2.0M
NVAX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 5:20 PM 08/27/14 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - NOVAVAX INC (NVAX)

Novavax, Inc. to Report Q2, 2014 on Aug 06, 2014
CapIQ 08/06/2014 9:00 PM ET
Novavax, Inc. to Report Q1, 2014 on May 07, 2014
CapIQ 08/06/2014 9:00 PM ET
Novavax, Inc. to Report Q4, 2013 on Mar 10, 2014
CapIQ 08/06/2014 9:00 PM ET

2013 revenues at Novavax, Inc. totaled $20.9M USD, while annual losses equaled $0.31 per share.

Quarterly Earnings & Estimates - NOVAVAX INC (NVAX)

Actuals vs. Estimates for NOVAVAX INC NVAX

Novavax, Inc.'s Quarterly Earnings

Novavax, Inc. reported 1st quarter 2014 losses of $0.07 per share on 05/9/2014.

Annual Earnings & Estimates - NOVAVAX INC (NVAX)

Actuals vs. Estimates for NOVAVAX INC NVAX

Novavax, Inc.'s Annual Earnings

Novavax, Inc. reported annual 2013 losses of $0.31 per share on 03/12/2014.

Quarterly Revenues - NOVAVAX INC (NVAX)

Actuals vs. Estimates for NOVAVAX INC NVAX

Novavax, Inc.'s Quarterly Revenues

Novavax, Inc. had 1st quarter 2014 revenues of $7.5M USD. This bettered the $6.8M USD consensus of the 2 analysts covering the company. This was 94.7% above the prior year's 1st quarter results.

Annual Revenues - NOVAVAX INC (NVAX)

Actuals vs. Estimates for NOVAVAX INC NVAX

Novavax, Inc.'s Annual Revenues

Novavax, Inc. had revenues for the full year 2013 of $20.9M USD. This was -5.3% below the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NVAX:US $4.73 USD -0.06

NVAX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Celldex Therapeutics Inc $16.15 USD -0.27
Dynavax Technologies Corp $1.42 USD -0.03
Inovio Pharmaceuticals Inc $10.75 USD +0.43
Progenics Pharmaceuticals Inc $5.43 USD -0.01
Transgene SA €8.44 EUR +0.01
View Industry Companies
 

Industry Analysis

NVAX

Industry Average

Valuation NVAX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 35.5x
Price/Book 4.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 33.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVAVAX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.